Personal tools

Coexpression cluster:C3053: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C3053_Eosinophils_Neutrophils_CD14_granulocyte_immature_CD8_Basophils |id=C3053 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C3053_Eosinophils_Neutrophils_CD14_granulocyte_immature_CD8_Basophils
|full_id=C3053_Eosinophils_Neutrophils_CD14_granulocyte_immature_CD8_Basophils
|id=C3053
|id=C3053
|ontology_enrichment_celltype=CL:0000037!3.92e-56!172;CL:0000566!3.92e-56!172;CL:0002032!1.48e-52!165;CL:0000837!1.48e-52!165;CL:0000738!2.94e-51!140;CL:0000988!3.90e-50!182;CL:0002031!4.91e-42!124;CL:0002087!4.58e-41!119;CL:0000763!9.88e-38!112;CL:0000049!9.88e-38!112;CL:0000766!1.49e-33!76;CL:0000557!3.66e-30!71;CL:0000839!2.61e-28!70;CL:0002009!7.63e-28!65;CL:0002194!1.12e-26!63;CL:0000576!1.12e-26!63;CL:0000040!1.12e-26!63;CL:0000559!1.12e-26!63;CL:0000860!9.02e-25!45;CL:0002057!4.80e-24!42;CL:0000542!9.04e-13!53;CL:0000051!9.04e-13!53;CL:0000838!2.12e-12!52
|ontology_enrichment_disease=DOID:2531!8.01e-07!51;DOID:0060083!8.01e-07!51
|ontology_enrichment_uberon=UBERON:0002390!1.81e-31!102;UBERON:0003061!1.81e-31!102;UBERON:0002193!2.91e-28!112;UBERON:0001474!4.45e-23!86;UBERON:0002371!4.94e-23!80;UBERON:0002405!1.90e-20!115;UBERON:0004765!1.04e-15!101;UBERON:0001434!1.04e-15!101;UBERON:0000178!7.56e-07!15;UBERON:0000179!7.56e-07!15;UBERON:0000463!7.56e-07!15
}}
}}

Revision as of 14:31, 21 May 2012


Full id: C3053_Eosinophils_Neutrophils_CD14_granulocyte_immature_CD8_Basophils



Phase1 CAGE Peaks

Hg19::chr10:88281494..88281570,-p1@WAPAL
Hg19::chr16:75498553..75498621,-p1@TMEM170A
Hg19::chr5:139781445..139781487,+p2@ANKHD1-EIF4EBP3
p2@ANKHD1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
hematopoietic stem cell3.92e-56172
angioblastic mesenchymal cell3.92e-56172
hematopoietic oligopotent progenitor cell1.48e-52165
hematopoietic multipotent progenitor cell1.48e-52165
leukocyte2.94e-51140
hematopoietic cell3.90e-50182
hematopoietic lineage restricted progenitor cell4.91e-42124
nongranular leukocyte4.58e-41119
myeloid cell9.88e-38112
common myeloid progenitor9.88e-38112
myeloid leukocyte1.49e-3376
granulocyte monocyte progenitor cell3.66e-3071
myeloid lineage restricted progenitor cell2.61e-2870
macrophage dendritic cell progenitor7.63e-2865
monopoietic cell1.12e-2663
monocyte1.12e-2663
monoblast1.12e-2663
promonocyte1.12e-2663
classical monocyte9.02e-2545
CD14-positive, CD16-negative classical monocyte4.80e-2442
lymphocyte9.04e-1353
common lymphoid progenitor9.04e-1353
lymphoid lineage restricted progenitor cell2.12e-1252
Uber Anatomy
Ontology termp-valuen
hematopoietic system1.81e-31102
blood island1.81e-31102
hemolymphoid system2.91e-28112
bone element4.45e-2386
bone marrow4.94e-2380
immune system1.90e-20115
skeletal element1.04e-15101
skeletal system1.04e-15101
blood7.56e-0715
haemolymphatic fluid7.56e-0715
organism substance7.56e-0715
Disease
Ontology termp-valuen
hematologic cancer8.01e-0751
immune system cancer8.01e-0751


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.